91 related articles for article (PubMed ID: 35478)
1. [Neuroleptic potency of bromperidol].
Kaumeier S; Haase HJ; Schwarz H; Gundel A; Linde OK; Maetz H; Scheel R; Stripf A; Stripf L
Int Pharmacopsychiatry; 1978; 13 Suppl 1():41-4. PubMed ID: 35478
[No Abstract] [Full Text] [Related]
2. [Report on an open investigation on bromperidol, a neuroleptic of the butyrophenone series].
Fleischhauer J
Int Pharmacopsychiatry; 1978; 13 Suppl 1():30-7. PubMed ID: 35476
[No Abstract] [Full Text] [Related]
3. [Tolerance of bromperidol in long term application].
Scelovic B
Int Pharmacopsychiatry; 1978; 13 Suppl 1():38-40. PubMed ID: 35477
[No Abstract] [Full Text] [Related]
4. [First application of tablet form bromperidol in man with particular consideration of tolerance].
Pöldinger W; Bures E
Int Pharmacopsychiatry; 1978; 13 Suppl 1():26-9. PubMed ID: 35474
[No Abstract] [Full Text] [Related]
5. [The use of bromperidol in an open study].
Hucker H
Int Pharmacopsychiatry; 1978; 13 Suppl 1():53-61. PubMed ID: 35480
[No Abstract] [Full Text] [Related]
6. [Results of a double blind study with bromperidol and perphenazine].
Woggon B
Int Pharmacopsychiatry; 1978; 13 Suppl 1():62-71. PubMed ID: 35481
[No Abstract] [Full Text] [Related]
7. [Influence of diagnosis, hospital and sex on the effects of bromperidol].
Woggon B; Fleischhauer J; Widmer A
Int Pharmacopsychiatry; 1979; 14(4):213-27. PubMed ID: 42629
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic potency of bromperidol.
Haase HJ; Kaumeier S; Schwarz H; Gundel A; Linde OK; Maetz H; Scheel R; Stripf A; Stripf L
Acta Psychiatr Belg; 1978; 78(1):83-8. PubMed ID: 347882
[TBL] [Abstract][Full Text] [Related]
9. [The maintenance dosage of neuroleptic agents].
Stolk PJ
Ned Tijdschr Geneeskd; 1987 Jul; 131(27):1158-9. PubMed ID: 2886929
[No Abstract] [Full Text] [Related]
10. [Clinical experience with the neuroleptic 19.366 R.P. (pipothiazine)].
Arrojo Lois M
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(3):309-12. PubMed ID: 31067
[No Abstract] [Full Text] [Related]
11. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
Johnson DA
J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
[TBL] [Abstract][Full Text] [Related]
12. [Initial experience with the neuroleptic Zetidoline in hospitalized schizophrenic patients].
Zapletálek M; Libiger J; Tůma I
Cesk Psychiatr; 1983 Apr; 79(2):83-8. PubMed ID: 6134590
[No Abstract] [Full Text] [Related]
13. Neuroleptic treatment of schizophrenia.
Lauriello J; Jeste DV
Compr Ther; 1992 Jan; 18(1):30-5. PubMed ID: 1346590
[No Abstract] [Full Text] [Related]
14. [Bromperidol decanoate in the residual phase of schizophrenia].
Smeraldi E; Cocconcelli C; Canova L; Faravelli C; Marchetti FP; Mariani G; Rapisarda V
Minerva Psichiatr; 1996 Mar; 37(1):39-44. PubMed ID: 8926856
[TBL] [Abstract][Full Text] [Related]
15. Central atropine-like toxicity in combined psychotropic drug administration.
el-Yousef MK; Davis JM; Janowsky DS; Fann WE
J Tenn Med Assoc; 1972 Aug; 65(8):719. PubMed ID: 4152620
[No Abstract] [Full Text] [Related]
16. The management of schizophrenia.
Bennett DH
Br J Psychiatry; 1975; Spec No 9():48-54. PubMed ID: 241452
[No Abstract] [Full Text] [Related]
17. Isofloxythepine in an open study.
Papezová H; David I; Alda M; Soucek R
Act Nerv Super (Praha); 1989 Jun; 31(2):121-2. PubMed ID: 2572133
[No Abstract] [Full Text] [Related]
18. [Clinical effectiveness of isofloxythepin--an open study].
Zapletálek M; Tůma I; Kudrnová K
Cesk Psychiatr; 1985 Aug; 81(4):242-6. PubMed ID: 2864141
[No Abstract] [Full Text] [Related]
19. Molindone--a new antipsychotic drug.
Med Lett Drugs Ther; 1975 Jul; 17(14):59. PubMed ID: 237228
[No Abstract] [Full Text] [Related]
20. Clinical effectiveness of piperacetazine injection in schizophrenic patients: a controlled study.
Kulkarni AS
Adv Biochem Psychopharmacol; 1974; 9(0):691-9. PubMed ID: 4151770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
